A recent academic publication finds THC concentrations have been on the rise over the last 50 years. A systematic review and meta-analysis was conducted on the changes in THC and …

Volteface is delighted to announce our new video series All Good Points, a Volteface Production in partnership with Hanway Associates. We will be providing you with a 30 minute weekly …

  As spring’s national lockdown was announced, professionals troubled over how such unparalleled change might affect people in recovery. The lack of connection, loss of routine and pause on vital …

  “The system here is basically a mess. People are being criminalised for being caught with joints, or tiny amounts of cannabis, as well as for growing cannabis and possessing …

  Covid-19 and mental health problems are two pandemics that have simultaneously collided.  The inextricable link between addiction and mental illness has been exacerbated by this pandemic. Spring lockdown saw …

  In July, the Conservative Drug Policy Reform Group (‘CDPRG’) produced the most compelling argument (so far) for rescheduling of psilocybin.[1]  It is now time to: Assess the impact of …

  There is just about any kind of CBD product you can think of – there are edibles (with vegan options because why not?), oil tinctures, cosmetic and skin care …

  Entering the drug reform space four years ago was a shock to the system. Despite years of working with the most complex and vulnerable populations in the UK, nothing …

  The changing legal status of cannabis, along with recognising its medical benefits has allowed the industry to continue to grow. As a result of this, alternative ways for consuming …

  Last Month Purdue Pharma, the producer of synthetic opiate Oxycontin, pleaded guilty to criminal charges. Purdue Pharma have entered into a $8.3bn (£6.3bn) settlement with the DoJ; which will see …